KREBSBIO.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 10, 2026

Report Source: 2026 2nd Quarter Report

Krebs Biochemicals and Industries Ltd

Krebs Biochemicals and Industries Ltd. Stock Analysis KREBSBIO.NS

India Health Care Nano Cap Report:
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. The firm manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The firm has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.
Read More

Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) Chart

Key Statistics of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹56.00₹56.17

Today's Open

₹56.00

Volume

1777.00

P/E Ratio (TTM)

-

52 Week Range

₹38.33₹113.50

Market Cap

1.27B

Avg. Volume

3078.36

Dividend Yield

-

Financial Metrics & Statements of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)

FAQ's for Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)

  • According to Musaffa’s Shariah screening methodology, Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.